High-Intensity Statins Benefit High-Risk Patients: Why and How to Do Better
Scott M. Grundy, Neil J. Stone, Roger S. Blumenthal, Lynne T. Braun, Paul A. Heidenreich, Donald M. Lloyd‐Jones, Carl E. Orringer, Joseph J. Saseen, Sidney C. Smith, Laurence Sperling, Salim S. Virani
Topics & Concepts
MedicineEzetimibeInternal medicineStatinPCSK9Coronary artery diseaseAtherosclerotic cardiovascular diseaseCardiologyProprotein convertaseCholesterolLipoproteinDiseaseLDL receptorLipoproteins and Cardiovascular HealthPharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life